J Fareed|J M Walenga|U Cornelli - JoVE Visualize

Showing results (11-20 of 400) with videos related to

Pageof 40

Sort By:

Seminars in Thrombosis and Hemostasis|April 1, 1985

Validity of serine protease inhibition tests in the evaluation and monitoring of the effect of heparin and its fractionsD A Hoppensteadt, J M Walenga, J Fareed

Seminars in Thrombosis and Hemostasis|January 1, 1985

In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169)J M Walenga, J Fareed, D A Hoppensteadt

Seminars in Thrombosis and Hemostasis|January 1, 1991

Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparinD A Hoppensteadt, J M Walenga, J Fareed

Seminars in Thrombosis and Hemostasis|April 1, 1985

A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractionsJ Fareed, J M Walenga, A Kumar, et al.

The Annals of Thoracic Surgery|May 1, 1992

Hemostatic abnormalities in total artificial heart patients as detected by specific blood markersJ M Walenga, D Hoppensteadt, J Fareed, et al.

Expert Opinion on Investigational Drugs|July 5, 2005

Synthetic and recombinant antithrombin drugsB Kaiser, D Callas, J M Walenga, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2000

Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human bloodB Kaiser, W Jeske, J M Walenga, et al.

Thrombosis Research|June 1, 1995

Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis modelK Fu, R Izquierdo, J M Walenga, et al.

Thrombosis Research|May 1, 1996

Flow cytometric evaluation of the effect of various thrombin inhibitors on platelet activation in whole bloodB Kaiser, M Koza, J M Walenga, et al.

Seminars in Thrombosis and Hemostasis|October 1, 1983

Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methodsL G Svendsen, J Fareed, J M Walenga, et al.

Pageof 40

Showing results (11-20 of 400) with videos related to

Sort By:

Pageof 40

Seminars in Thrombosis and Hemostasis|April 1, 1985

Validity of serine protease inhibition tests in the evaluation and monitoring of the effect of heparin and its fractionsD A Hoppensteadt, J M Walenga, J Fareed

Seminars in Thrombosis and Hemostasis|January 1, 1985

In vitro coagulant and amidolytic methods for evaluating the activity of heparin and a low molecular weight derivative (PK 10169)J M Walenga, J Fareed, D A Hoppensteadt

Seminars in Thrombosis and Hemostasis|January 1, 1991

Effect of dermatan sulfate and heparan sulfate on platelet activity compared to heparinD A Hoppensteadt, J M Walenga, J Fareed

Seminars in Thrombosis and Hemostasis|April 1, 1985

A modified stasis thrombosis model to study the antithrombotic actions of heparin and its fractionsJ Fareed, J M Walenga, A Kumar, et al.

The Annals of Thoracic Surgery|May 1, 1992

Hemostatic abnormalities in total artificial heart patients as detected by specific blood markersJ M Walenga, D Hoppensteadt, J Fareed, et al.

Expert Opinion on Investigational Drugs|July 5, 2005

Synthetic and recombinant antithrombin drugsB Kaiser, D Callas, J M Walenga, et al.

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2000

Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human bloodB Kaiser, W Jeske, J M Walenga, et al.

Thrombosis Research|June 1, 1995

Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis modelK Fu, R Izquierdo, J M Walenga, et al.

Thrombosis Research|May 1, 1996

Flow cytometric evaluation of the effect of various thrombin inhibitors on platelet activation in whole bloodB Kaiser, M Koza, J M Walenga, et al.

Seminars in Thrombosis and Hemostasis|October 1, 1983

Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methodsL G Svendsen, J Fareed, J M Walenga, et al.

Pageof 40